SCHEMBL2322982

SCHEMBL2322982

CCN1CCN(c2ccc(Nc3cc(CNC(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 15/20 0.70
FGFR1 P11362 10/20 0.70
FGFR4 P22455 9/20 0.70
FGFR2 P21802 7/20 0.70
JAK2 O60674 2/20 0.70
ABL1 P00519 2/20 0.70
INSR P06213 2/20 0.70
LCK P06239 2/20 0.70
FYN P06241 2/20 0.70
YES1 P07947 2/20 0.70
LYN P07948 2/20 0.70
RET P07949 2/20 0.70
MET P08581 2/20 0.70
ROS1 P08922 2/20 0.70
KIT P10721 2/20 0.70
SRC P12931 2/20 0.70
BRAF P15056 2/20 0.70
PDGFRA P16234 2/20 0.70
FLT1 P17948 2/20 0.70
TYK2 P29597 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL16910190 0.97 FGFR3 (0.71) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL374703 0.89 FGFR3 (0.75) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL2010587 0.85 FGFR3 (0.69) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL14482660 0.84 HCK (0.51) FGFR3FGFR1FGFR4FGFR2JAK2
Infigratinib SCHEMBL374435 0.82 FGFR3 (1.00) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL2017841 0.82 FGFR3 (0.84) FGFR3FGFR1FGFR4FGFR2JAK2
Infigratinib SCHEMBL14893408 0.80 FGFR3 (1.00) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL374246 0.79 FGFR3 (0.70) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL16383021 0.79 FGFR3 (0.92) FGFR3FGFR1FGFR4FGFR2JAK2
SCHEMBL23281490 0.78 FGFR3 (0.91) FGFR3FGFR1FGFR4FGFR2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761505-B1 PYRIMIDINE UREA DERIVATIVES AS KINASE INHIBITORS NOVARTIS AG (CH) 2011-08-17 EP claimed
EP-2409969-B1 Pyrimidine urea derivatives as kinase inhibitors NOVARTIS AG (CH) 2013-07-24 EP disclosed